BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 8236422)

  • 1. Red cell collection by apheresis technology.
    Meyer D; Bolgiano DC; Sayers M; Price T; Benson D; Slichter SJ
    Transfusion; 1993 Oct; 33(10):819-24. PubMed ID: 8236422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged iron depletion after allogeneic 2-unit RBC apheresis.
    Högler W; Mayer W; Messmer C; Eibl G; Innerhofer P; Schönitzer D; Nussbaumer W
    Transfusion; 2001 May; 41(5):602-5. PubMed ID: 11346693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of allogeneic 2-RBC apheresis on iron stores of Brazilian blood donors.
    Mendrone A; Arrais CA; Almeida Neto C; Gualandro Sde F; Dorlhiac-Llacer PE; Chamone Dde A; Sabino EC
    Transfus Apher Sci; 2009 Aug; 41(1):13-7. PubMed ID: 19615943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoration of red blood cell volume following 2-unit red blood cell apheresis.
    Valeri CR; Ragno G; Srey R
    Vox Sang; 2003 Aug; 85(2):85-7. PubMed ID: 12925159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron supplementation and 2-unit red blood cell apheresis: a randomized, double-blind, placebo-controlled study.
    Radtke H; Mayer B; Röcker L; Salama A; Kiesewetter H
    Transfusion; 2004 Oct; 44(10):1463-7. PubMed ID: 15383019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of serum ferritin in donors of two red blood cells units collected by apheresis.
    González ML; Maia S; Mesquita P; Bessa M
    Transfus Apher Sci; 2013 Oct; 49(2):238-43. PubMed ID: 23810218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of repeat apheresis donors in Japan.
    Furuta M; Shimizu T; Mizuno S; Kamiya T; Ozawa K; Nakase T; Tadokoro K; Takenaka M; Ohkawa T; Yokoyama S; Ogawa Y; Kiyokawa H; Shimizu M; Sekine N; Yoshimura I
    Vox Sang; 1999; 77(1):17-23. PubMed ID: 10474086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral iron supplementation after blood donation: a randomized clinical trial.
    Kiss JE; Brambilla D; Glynn SA; Mast AE; Spencer BR; Stone M; Kleinman SH; Cable RG;
    JAMA; 2015 Feb; 313(6):575-83. PubMed ID: 25668261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron Store of Repeat Plasma and Platelet Apheresis Donors.
    Pfeiffer H; Hechler J; Zimmermann R; Hackstein H; Achenbach S
    Clin Lab; 2021 Feb; 67(2):. PubMed ID: 33616348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matching blood donations to type-specific product needs: a recruitment technique.
    Kuriyan M; Wells S
    J Clin Apher; 1995; 10(1):23-6. PubMed ID: 7601863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of repeated blood donations on the iron status of Iranian blood donors attending the Iranian blood transfusion organization.
    Djalali M; Neyestani TR; Bateni J; Siassi F
    Int J Vitam Nutr Res; 2006 May; 76(3):132-7. PubMed ID: 17048192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent source plasma donors are not at risk of iron depletion: the Ferritin Levels in Plasma Donor (FLIPD) study.
    Schreiber GB; Brinser R; Rosa-Bray M; Yu ZF; Simon T
    Transfusion; 2018 Apr; 58(4):951-959. PubMed ID: 29520799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose intravenously administered iron versus orally administered iron in blood donors with iron deficiency: study protocol for a randomised, controlled trial.
    Macher S; Drexler C; Lindenau I; Sareban N; Schlenke P; Amrein K
    Trials; 2016 Oct; 17(1):527. PubMed ID: 27793204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse events and retention of donors of double red cell units by apheresis.
    Keshelashvili K; O'meara A; Stern M; Jirout Z; Pehlic V; Holbro A; Buser A; Sigle J; Infanti L
    Blood Transfus; 2016 Sep; 14(5):391-9. PubMed ID: 27136442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zinc protoporphyrin as screening test in female blood donors.
    Harthoorn-Lasthuizen EJ; Lindemans J; Langenhuijsen MM
    Clin Chem; 1998 Apr; 44(4):800-4. PubMed ID: 9554491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening with zinc protoporphyrin for iron deficiency in non-anemic female blood donors.
    Jensen BM; Sandø SH; Grandjean P; Wiggers P; Dalhøj J
    Clin Chem; 1990 Jun; 36(6):846-8. PubMed ID: 2357820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zinc Protoporphyrin-to-Heme Ratio and Ferritin as Measures of Iron Sufficiency in the Neonatal Intensive Care Unit.
    German K; Vu PT; Grelli KN; Denton C; Lee G; Juul SE
    J Pediatr; 2018 Mar; 194():47-53. PubMed ID: 29212619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence, incidence, and residual risk of major blood-borne infections among apheresis collections to the American Red Cross Blood Services, 2004 through 2008.
    Zou S; Musavi F; Notari EP; Stramer SL; Dodd RY
    Transfusion; 2010 Jul; 50(7):1487-94. PubMed ID: 20345571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of multicomponent apheresis on donors' haematological and coagulation parameters, iron storage and platelet function.
    Macher S; Sipurzynski-Budraβ S; Rosskopf K; Semmelrock M; Prüller F; Griesbacher A; Lanzer G; Schallmoser K
    Vox Sang; 2012 Oct; 103(3):194-200. PubMed ID: 22471611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron stores assessed in blood donors by hematofluorometry.
    Raftos J; Schuller M; Lovric VA
    Transfusion; 1983; 23(3):226-8. PubMed ID: 6679377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.